MoneyWorks4Me

Parenteral Drugs (India) submits confirmation certificate

29 Jan 2021 Evaluate

Parenteral Drugs (India) has informed that pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, the Company enclosed Confirmation Certificate for dematerialization requests, cancellation of certificates and consequential actions, if any, as received from Link Intime India, RTA of the Company for the third quarter of the financial year 2020-21 ended on 31st December, 2020.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1777.90
Dr. Reddys Labs. 1196.10
Cipla 1332.70
Lupin 2011.60
Zydus Lifesciences 1151.90
View more..